Rep. Andrea Salinas

Allows employee of school district or education service district, or employee's exclusive representative, to challenge cost analysis for procurement that school district or education service district conducted. Modifies procedure by which school district and education service district conduct cost analysis before procurement and awarding of contract. Takes effect on 91st day after adjournment sine die.

Requires health benefit plan to reimburse cost of covered telemedicine health service provided by health professional licensed or certified in this state if same health service is provided in person.

Provides that persons representing or speaking on behalf of certain taxpayers may be subject to sanction by either house of Legislative Assembly if they make false statement or misrepresentation to legislative official concerning tax liability or tax consequences of law or proposed law. Establishes defense if person corrects false statement or misrepresentation by specified time. Requires Department of Revenue to provide notice to legislative official to whom false statement or misrepresentation was made, if department is aware of false statement or misrepresentation. Limits content of notice.

Directs Department of Revenue to deliver vouchers to certain personal income taxpayers who fail to use income tax credit for political contribution in previous tax year. Provides for delivery of vouchers to political party, or committee thereof, candidate or political committee, for redemption by department. Applies to tax years beginning on or after January 1, 2019. Takes effect on 91st day following adjournment sine die.

Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services total cost of patient assistance programs and information on financial assistance provided to pharmacies, government agencies and advocacy organizations. Excludes proprietary information from disclosure on department's website. Requires state-sponsored programs that use pharmacy benefit managers to use fee-only pharmacy benefit managers. Requires insurers to post specified information regarding formulary, tiers and costs to insurer's website. Requires 60-day advance notice to enrollees adversely affected by change in formulary. Requires insurer and allows pharmacy to notify insured that if cash price for drug is less than insured's cost-share for drug, insured may pay cash price and expense must be counted toward deductible or out-of-pocket maximum. Requires hospitals and other medical providers to disclose in patient billing information regarding mark-up on price of drug. Also requires billing to disclose price of drug charged to specified state agencies and insurers. Requires specified state agencies to report to Legislative Assembly on high-cost drugs. Requires Oregon Health Authority to refer to Pharmacy and Therapeutics Committee any drug exceeding specified cost. Requires patient advocacy organization with budget exceeding $50,000 that has registered lobbyist in this state to report to Oregon Government Ethics Commission and Oregon Health Authority specified information regarding funding received from participants in pharmaceutical supply chain. Requires pharmacy benefit managers to report to Department of Consumer and Business Services and plan sponsors specified information regarding rebates, reimbursements, fees and incentives paid for drugs by manufacturers, insurers and pharmacies. Requires drug advertisement to disclose wholesale price of drug.

Prohibits anyone other than patient from administering medication to end patient's life in humane and dignified manner. Defines "self-administer . " to include ingestion or other delivery method. ] Takes effect on 91st day following adjournment sine die.

Prohibits anyone other than patient from administering medication to end patient's life in humane and dignified manner. Defines "self-administer." Expands definition of "terminal disease." Permits patient to request medication to end patient's life in humane and dignified manner no earlier than 90 days after receiving terminal diagnosis. Creates exception to 90-day waiting period for patient with less than six months to live.

Requires pharmacy or pharmacist to substitute prescribed biological product with interchangeable biological product. Declares emergency, effective on passage.

Prohibits sale, purchase or use of pesticide chlorpyrifos. ] Requires State Department of Agriculture to place pesticide products containing neonicotinoid on list of restricted-use pesticides. ] Requires State Department of Agriculture to review current scientific data regarding safety of pesticide products containing chlorpyrifos. Requires department to report findings and recommendations to interim committee of Legislative Assembly no later than January 1, 2020. Requires department to review data for registered pesticide products containing chlorpyrifos and add additional restrictions as warranted. Sunsets January 2, 2024. Declares emergency, effective on passage.

Directs Department of Education to conduct study related to reengaging into school persons who dropped out of public secondary schools. Directs department to submit report to interim committee of Legislative Assembly no later than September 15, 2020. Sunsets December 31, 2020. Declares emergency, effective on passage.